Search Within

Roisin Eilish O'Cearbhaill

Formats
  1. Meeting Abstract (128)
  2. Journal Article (125)
  3. Review (9)
  4. Editorial (6)
  5. Book Section (3)
  6. Guidelines (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (274)
  2. GDMT, Medicine (274)
  3. Gynecologic Medicine Service (274)
  4. Gynecology Disease Management Team (274)
  5. Hematologic Malignancies, Division of (274)
  6. Solid Tumor Oncology Division (274)

More Groups

People
  1. Carol Aghajanian (99)
  2. Alexia Iasonos (75)
  3. Qin Zhou (68)
  4. Rachel Grisham (68)
  5. Dennis Chi (67)
  6. William Tew (66)

More People

Years
  1. 2025 (16)
  2. 2024 (30)
  3. 2023 (43)
  4. 2022 (31)
  5. 2021 (25)
  6. 2020 (41)

More Years

Publications
  1. Gynecologic Oncology (91)
  2. Journal of Clinical Oncology (46)
  3. International Journal of Gynecological Cancer (39)
  4. Annals of Oncology (13)
  5. Gynecologic Oncology Reports (11)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier B.V. (102)
  2. American Society of Clinical Oncology (49)
  3. Lippincott Williams & Wilkins (40)
  4. Oxford University Press (14)
  5. American Association for Cancer Research (13)
  6. Nature Publishing Group (10)

More Publishers

Results (274)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Creating a multidisciplinary protocol for the administration of hyperthermic intraperitoneal chemotherapy with cisplatin: A single-institution experience
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Dessources, K.; Sonoda, Y.; Roche, K. L.; Gardner, G.; Tew, W.; Grisham, R.; Chi, D.; O'Cearbhaill, R.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center
    Meeting Abstract

    Ehmann, S.; Shay, K.; Zhou, Q.; Iasonos, A.; Sonoda, Y.; Gardner, G.; Roche, K. L.; Zammarrelli, W.; O'Cearbhaill, R.; Zivanovic, O.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: Interim Results of ENGOT Cx8/GOG-3024/innovaTV205
    Meeting Abstract

    Lorusso, D.; Vergote, I.; O'Cearbhaill, R. E.; Westermann, A. M.; Banerjee, S.; van Nieuwenhuysen, E.; Iglesias, D. A.; Collins, D.; Cibula, D.; Madsen, K.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer - Going to the next level: A Memorial Sloan Kettering team ovary study
    Meeting Abstract

    Kahn, R.; McMinn, E.; Boerner, T.; Roche, K. L.; Zivanovic, O.; Gardner, G.; Sonoda, Y.; O'Cearbhaill, R.; Grisham, R.; Huang, J.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Postoperative morbidity after secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer: An exploratory analysis of a randomized phase II study evaluating hyperthermic intraperitoneal chemotherapy
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Chi, D.; Sonoda, Y.; Roche, K. L.; Gardner, G.; Tew, W.; Grisham, R.; O'Cearbhaill, R.; Zivanovic, O.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Predicting outcomes in female germ cell patients using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
    Meeting Abstract

    Manning-Geist, B.; Deng, L.; Knezevic, A.; Bromberg, M.; Funt, S.; Zivanovic, O.; Roche, K. L.; Sonoda, Y.; Gardner, G.; Grisham, R.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Safety and immunogenicity of anti PD-L1 (atezolizumab) given as an immune primer or concurrently with extended field chemoradiotherapy for node positive locally advanced cervical cancer: An NRG oncology trial
    Meeting Abstract

    Mayadev, J.; Zamarin, D.; Deng, W.; Lankes, H.; Pesci, G.; Park, K.; Banbury, B.; Sherry, N.; Ghamande, S.; Holman, L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy of niraparib by timing of surgery and residual disease: A post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
    Meeting Abstract

    O'Cearbhaill, R.; Grabowski, J.; PeĢrez-Fidalgo, J. A.; Monk, B. J.; Tusquets, I.; Mccormick, C.; Pradera, J. F.; Moore, R. G.; Vulsteke, C.; Shahin, M.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • PRIMA/ENGOT-OV26/GOG-3012 study: Updated long-term PFS and safety
    Meeting Abstract

    Gonzalez Martin, A. J.; Pothuri, B.; Vergote, I. B.; Graybill, W.; Mirza, M. R.; Mccormick, C.; Lorusso, D.; Freyer, G.; Backes, F.; Baumann, K. H.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Ubamatamab (REGN4018, MUC16xCD3 bispecific antibody) monotherapy in patients with recurrent ovarian cancer (OC): Phase I dose-escalation analysis
    Meeting Abstract

    Van Nieuwenhuysen, E.; O'Malley, D.; O'Cearbhaill, R. E.; Moore, K. N.; Hamilton, E. P.; Yeku, O.; Bouberhan, S.; Hou, J. Y.; Yoo, S. Y.; Brouwer-Visser, J.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save